Amyaouch Bradaïa

TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity

Florent G. Revel, Jean‐Luc Moreau, Raul R. Gainetdinov et al. · Proceedings of the National Academy of Sciences · 2011 · 365 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Trace Amine-Associated Receptor 1 Modulates Dopaminergic Activity

Lothar Lindemann, Claas A. Meyer, Karine Jeanneau et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 352 citations

Life Sciences, Neurobiology, Neuroscience +17

Characterization of Neurophysiological and Behavioral Changes, MRI Brain Volumetry and 1H MRS in zQ175 Knock-In Mouse Model of Huntington's Disease

Taneli Heikkinen, Kimmo Lehtimäki, Nina Vartiainen et al. · PLoS ONE · 2012 · 325 citations · Full text

Life Sciences, Neurology, Neuroscience +17

A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight

F. Revel, J‐L Moreau, Bruno Pouzet et al. · Molecular Psychiatry · 2012 · 286 citations

Medicine, Neuroscience, Pharmacology +16

The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system

Amyaouch Bradaïa, Gerhard Trube, Henri Stalder et al. · Proceedings of the National Academy of Sciences · 2009 · 250 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17